153 related articles for article (PubMed ID: 33358905)
1. Identification of metastasis-related genes by genomic and transcriptomic studies in murine melanoma.
Kadioglu O; Saeed MEM; Mahmoud N; Hussein Azawi SS; Rincic M; Liehr T; Efferth T
Life Sci; 2021 Feb; 267():118922. PubMed ID: 33358905
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel drug resistance mechanisms by genomic and transcriptomic profiling of glioblastoma cells with mutation-activated EGFR.
Kadioglu O; Saeed MEM; Mahmoud N; Azawi S; Mrasek K; Liehr T; Efferth T
Life Sci; 2021 Nov; 284():119601. PubMed ID: 33991550
[TBL] [Abstract][Full Text] [Related]
3. Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials.
Ishiguro T; Nakajima M; Naito M; Muto T; Tsuruo T
Cancer Res; 1996 Feb; 56(4):875-9. PubMed ID: 8631027
[TBL] [Abstract][Full Text] [Related]
4. Molecular Cytogenetic Characterization of the Murine Melanoma Cell Lines S91 Clone M3 and B16-F1 with Variant B16-4A5.
Piaszinski K; Rincic M; Liehr T; Azawi S
Cytogenet Genome Res; 2021; 161(1-2):82-92. PubMed ID: 33596583
[TBL] [Abstract][Full Text] [Related]
5. Rate of generation of major karyotypic abnormalities in relationship to the metastatic potential of B16 murine melanoma.
Kendal WS; Wang RY; Hsu TC; Frost P
Cancer Res; 1987 Jul; 47(14):3835-41. PubMed ID: 3594440
[TBL] [Abstract][Full Text] [Related]
6. Role of thymosin beta4 in tumor metastasis and angiogenesis.
Cha HJ; Jeong MJ; Kleinman HK
J Natl Cancer Inst; 2003 Nov; 95(22):1674-80. PubMed ID: 14625258
[TBL] [Abstract][Full Text] [Related]
7. Genomic and transcriptomic profiling of resistant CEM/ADR-5000 and sensitive CCRF-CEM leukaemia cells for unravelling the full complexity of multi-factorial multidrug resistance.
Kadioglu O; Cao J; Kosyakova N; Mrasek K; Liehr T; Efferth T
Sci Rep; 2016 Nov; 6():36754. PubMed ID: 27824156
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells.
Humphries MJ; Yamada KM; Olden K
J Clin Invest; 1988 Mar; 81(3):782-90. PubMed ID: 3343338
[TBL] [Abstract][Full Text] [Related]
9. 99mTc- and 111In-labeled alpha-melanocyte-stimulating hormone peptides as imaging probes for primary and pulmonary metastatic melanoma detection.
Miao Y; Benwell K; Quinn TP
J Nucl Med; 2007 Jan; 48(1):73-80. PubMed ID: 17204701
[TBL] [Abstract][Full Text] [Related]
10. Stress hormones promote growth of B16-F10 melanoma metastases: an interleukin 6- and glutathione-dependent mechanism.
Valles SL; Benlloch M; Rodriguez ML; Mena S; Pellicer JA; Asensi M; Obrador E; Estrela JM
J Transl Med; 2013 Mar; 11():72. PubMed ID: 23517603
[TBL] [Abstract][Full Text] [Related]
11. Enhanced metastasis of B16 melanoma cells by unexpected elevated expression of the metastasis-associated TI-241 (LRF-1-, Jun-Fos-related) gene treated with antisense oligonucleotide.
Ishiguro T; Naito M; Hanaoka K; Nagawa H; Muto T; Tsuruo T
Clin Exp Metastasis; 1998 Feb; 16(2):179-83. PubMed ID: 9514099
[TBL] [Abstract][Full Text] [Related]
12. Differential cell- and immuno-biological properties of murine B16-F1 and F10 melanomas: oncogene c-fos expression, sensitivity to LAK cells and/or IL-2, and components of gangliosides.
Nakayama J; Urabe K; Tsuchida T; Urabe A; Terao H; Taniguchi S; Hori Y
J Dermatol; 1995 Aug; 22(8):549-59. PubMed ID: 7560451
[TBL] [Abstract][Full Text] [Related]
13. Expression of the fos oncogene in B16 melanoma cells exhibiting different metastatic abilities.
Urabe A; Nakayama J; Taniguchi S; Inoue M; Hori Y
J Dermatol Sci; 1990 Nov; 1(6):455-8. PubMed ID: 2126954
[TBL] [Abstract][Full Text] [Related]
14. Characterization of mouse melanoma cell lines by their mortal malignancy using an experimental metastatic model.
Nakamura K; Yoshikawa N; Yamaguchi Y; Kagota S; Shinozuka K; Kunitomo M
Life Sci; 2002 Jan; 70(7):791-8. PubMed ID: 11833741
[TBL] [Abstract][Full Text] [Related]
15. Characterization of plasma membrane shedding from murine melanoma cells.
Taylor DD; Taylor CG; Jiang CG; Black PH
Int J Cancer; 1988 Apr; 41(4):629-35. PubMed ID: 3356493
[TBL] [Abstract][Full Text] [Related]
16. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials.
LeGrue SJ; Hearn DR
Cancer Res; 1983 Nov; 43(11):5106-11. PubMed ID: 6616449
[TBL] [Abstract][Full Text] [Related]
17. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines.
Wang BS; McLoughlin GA; Richie JP; Mannick JA
Cancer Res; 1980 Feb; 40(2):288-92. PubMed ID: 7356511
[TBL] [Abstract][Full Text] [Related]
18. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
[TBL] [Abstract][Full Text] [Related]
19. Tumor microenvironment modulates hyaluronan expression: the lactate effect.
Rudrabhatla SR; Mahaffey CL; Mummert ME
J Invest Dermatol; 2006 Jun; 126(6):1378-87. PubMed ID: 16543892
[TBL] [Abstract][Full Text] [Related]
20. Differences in cytotoxic effects of activated murine peritoneal macrophages and J774 monocytic cells on metastatic variants of B16 melanoma.
Miner KM; Klostergaard J; Granger GA; Nicolson GL
J Natl Cancer Inst; 1983 Apr; 70(4):717-24. PubMed ID: 6339778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
